{
    "nctId": "NCT00152178",
    "briefTitle": "The Comparative Trial of UFT + TAM With CMF + TAM in Adjuvant Therapy for Breast Cancer (CUBC)",
    "officialTitle": "The Comparative Trial of UFT + TAM With CMF + TAM in Adjuvant Therapy for Breast Cancer (CUBC)",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 680,
    "primaryOutcomeMeasure": "Relapse-free survival",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Age 20 to 65\n* Hematopoietic WBC \u2265 4,000/mm\\^3 Platelet \u2265 100,000/mm\\^3 Hemoglobin \u2265 11.0 g/dL\n* Hepatic AST and ALT \u2264 40 U/L Total bilirubin \u2264 1.5 mg/dL\n* Renal BUN \u2264 25 mg/dL Creatinine \u2264 1.5 mg/dL",
    "sex": "FEMALE",
    "minimumAge": "20 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}